AIMERBIO
AimerBio is a pharmaceutical company that engages in the long-term modification of peptides and peptide-drug conjugation technology. At present, it has three technology platforms for peptide drug design, optimization and screening, long-acting peptide modification technology, peptide conjugated drugs, and 1 related invention patent. The company focuses on the field of peptide drugs, integrates today's international advanced peptide technology, establishes a peptide drug innovation technology platform, R&D pipeline, and product pipeline, and provides process technology development services and commercial production services for cooperative units. A first-class peptide pharmaceutical company.
AIMERBIO
Industry:
Biopharma Biotechnology Medical Pharmaceutical
Founded:
2018-09-01
Address:
Hefei, Anhui, China
Country:
China
Status:
Active
Similar Organizations
Axceso Biopharma
Axceso Biopharma develops pharmaceutics that uses ' Aceso', the goddess of healing wounds and diseases in Greek mythology.
Intech Biopharm
Intech Biopharm is a pharmaceutical company that develops, produces and markets specialized drugs focused on respiratory treatment.
Twinings
Twinings is a biotech company that works in industrialization of biological fermentation technology.
UPPTHERA
UPPTHERA is a pharmaceutical company that specializes in drug development using targeted protein degradation technology.
Wize Pharma
Wize Pharma is a pharmaceutical company that focuses on the treatment of ophthalmic disorders, including DES.
More informations about "AimerBio"
AimerBio - Crunchbase Company Profile & Funding
AimerBio is a pharmaceutical company that engages in the long-term modification of peptides and peptide-drug conjugation technology. There is no recent news or activity for this profile.See details»
AimerBio - Crunchbase
AimerBio is a pharmaceutical company that engages in the long-term modification of peptides and peptide-drug conjugation technology. Search Crunchbase. Start Free Trial . Chrome Extension. Solutions. Products. Resources. Pricing. …See details»
New biotech company to facilitate industrial development
AIMERBIO (Hefei), a new biotech company focusing on polypeptide drugs, was established in Hefei National High-Tech Industry Development Zone in Anhui province on April 20. As a …See details»
AIMERS PROFILE – Artificial Intelligence Medical and Engineering ...
Vision and Leadership: Under his leadership, AIMER Society has grown into a premier organization advancing AI and medical engineering research. Achievements : His strategic …See details»
OBIO®
OBIO® supports early-stage and venture-backed life sciences and health tech companies enabling them to raise capital, hire and train industry-ready talent, facilitate the …See details»
Home Page - Canada’s Immunoengineering and Biomanufacturing …
Canada’s Immuno-Engineering and Biomanufacturing Hub (CIEBH) is bringing together a coalition of partners to accelerate the development and manufacturing of lifesaving medicines …See details»
AIM & VISION – Artificial Intelligence Medical and Engineering ...
Our vision is to establish the Artificial Intelligence Medical and Engineering Researchers Society (AIMERS) as a premier global institution at the forefront of AI-driven advancements in …See details»
AIMEDBIO - Funding, Financials, Valuation & Investors - Crunchbase
Sep 13, 2023 Organization. AIMEDBIO . Connect to CRM . Save . Summary. Financials. People. Technology. Signals & News. Similar Companies. Highlights. Funding Rounds 2. Lead …See details»
Celebrating partnerships to save more lives, sooner
Nov 14, 2023 Looking ahead, Dr. Chen Wan, Senior Research and Innovation Manager, Health, Genome BC, shared her organization’s support for the hub as part of their commitment to …See details»
Ngen supports commercial scale manufacturing of cell and
Sep 20, 2022 NGen is the industry-led not-for-profit organization that leads Canada’s Global Innovation Cluster for Advanced Manufacturing. Its mandate is to help build world-leading …See details»
Ensuring Canada’s Leading Role in AI-Driven Biotech
Mar 19, 2024 Canada’s Early Wins in Bioscience and AI. We can be proud of Canada’s early innovation in both the biosciences and AI. It was a team of Canadian researchers that …See details»
The neglected epidemic: Meridius Bio tackles chronic wounds with …
Apr 22, 2024 Jon Stojan is a professional writer based in Wisconsin. He guides editorial teams consisting of writers across the US to help them become more skilled and diverse writers.See details»
OmniaBio Inc. announces private investor
May 31, 2022 OmniaBio is expected to be Canada’s largest contract development and manufacturing organization (CDMO) for the manufacture of cell and gene therapies. OmniaBio …See details»
AI Medical Engg Research Group (@aimersociety) - Instagram
268 Followers, 20 Following, 57 Posts - AI Medical Engg Research Group (@aimersociety) on Instagram: "Professional body of Medicos,Engineers , Professionals and Academicians aim to …See details»
Search Here - Venture Capital Post
Mar 20, 2024 The team at Meridius Bio isn't leaving longevity to chance. They are taking luck out of the equation for millions affected by heart disease, diabetes, and a multitude of other …See details»
RNA editing start-up Amber Bio launches with $26 million
Aug 4, 2023 According to the firm’s scientific founders, this mass gene editing technique is more scalable than creating a drug for every disease-causing mutation.See details»
Major health and bioscience merger to fuel new research, …
May 18, 2023 By combining forces as a new organization, they can better support health and bioscience research and that will benefit all New Brunswickers. The NBHRF is an innovation …See details»
The AIMe registry for artificial intelligence in biomedical research
Aug 25, 2021 Organization structure. There are three different roles in which scientists from the field of biomedical AI can participate in and contribute to the AIMe initiative: as a registry user, …See details»
AIMEDBIO - Crunchbase Company Profile & Funding
AIMEDBIO provides therapeutic solutions to patients with serious brain diseases. Seoul, Seoul-t'ukpyolsi, South Korea; 11-50; Venture - Series Unknown; Private; www ...See details»
Meet the Founders - Aimer Development - Sprout Agritech
Mar 29, 2022 Imagine having the potential to earn an extra $500 per hectare just by using artificial intelligence. This is what Jeremy Bryant, founder of Aimer Development, estimates the …See details»